Write in a clean editor, then format for ACS Pharmacology & Translational Science in one click — DocuGuru applies the official American Chemical Society template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
ACS Pharmacology & Translational Science is a peer-reviewed journal published by American Chemical Society, covering Receptor Mechanisms and Signaling, Academic Writing and Publishing, Computational Drug Discovery Methods. Over its lifetime it has published 1,578 papers, which have received 20,546 citations.
| Publisher | American Chemical Society |
|---|---|
| Reference style | Superscript numbered (ACS) Superscript — small raised numerals in the text (1) Smith, A.; Jones, B.; Lee, C. A Representative Article Title. ACS Pharmacology & Translational Science 2023, 12, 45–58.
Formats any DOI in ACS Pharmacology & Translational Science style. No sign-up. |
| Publishes research in | Receptor Mechanisms and Signaling Academic Writing and Publishing Computational Drug Discovery Methods Neuropeptides and Animal Physiology SARS-CoV-2 and COVID-19 Research |
| ISSN | 2575-9108 |
| Citation impact (2-yr) | 4.16 |
| h-index | 62 |
| i10-index | 507 |
| Top institutions publishing here | National Institutes of Health |
| Journal website | pubs.acs.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
DNA-encoded chemical libraries (DELs) represent a versatile and powerful technology platform for the discovery of small-molecule ligands to protein targets of biological and pharmaceutical interest. DELs are collections of molecules, individually coupled to distinctive DNA tags serving as amplifiable identification barcodes. Thanks to advances in DNA-compatible reactions, selection methodologies, next-generation sequencing, and data analysis, DEL…
, and copper-derived chemicals. The surface protection mechanisms of the materials against the pathogen colonies are discussed in detail, which highlights the key differences that could determine the parameters that would govern the future development of advanced antibacterial and antiviral materials and surfaces.
Among the drug targets being investigated for SARS-CoV-2, the viral main protease (Mpro) is one of the most extensively studied. Mpro is a cysteine protease that hydrolyzes the viral polyprotein at more than 11 sites. It is highly conserved and has a unique substrate preference for glutamine in the P1 position. Therefore, Mpro inhibitors are…
inhibitors that may have potential for further clinical evaluation as part of drug combination therapies to treating COVID-19 patients and as starting points for chemistry optimization for new drug development.
